Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 203

Researchers are closing in on long covid

Posted by fidest press agency su martedì, 4 maggio 2021

Welcome to our weekly newsletter highlighting The Economist’s best coverage of the pandemic and its effects. In our Science section, we look at how scientists are closing in on understanding “long covid”. Many months after their initial infection with covid-19, some people still suffer from a range of debilitating symptoms including severe breathlessness, fatigue or “brain fog”. How should countries respond to this impending public-health emergency? In a leader, we argue that health-care systems and employers must prepare to assist long-covid sufferers. We also cover the topic on “Babbage”, our science podcast.Many Indians are up in arms about the government’s handling of their country’s all-engulfing second wave of covid-19. Hospitals, testing facilities, even crematoria are overwhelmed. Vaccines are in short supply. But where the government may have fallen short, civil society has stepped up. We published a correspondent’s diary from Delhi, where “acquaintances are dying faster than they can be counted”, while in our sister magazine, 1843, Sudipto Sanyal wrote about the collapse of the health-care system in Kolkata. For many Australians, quarantine cannot be too tough. States there keep ordering snap lockdowns because they are nervous about more contagious strains of covid-19 and most foreigners are barred from entering the country. A poll in February found that 71% of Aussies want to keep the international border closed until the “public health crisis has passed”. America has locked up supplies of covid vaccines that it does not need. As global recorded cases of covid-19 reach the highest levels of the pandemic so far, President Joe Biden is pursuing a vaccination policy that might well be branded with a favourite tagline of his predecessor, Donald Trump: America First.Meanwhile, many countries have turned to China and Russia for help. A new report by the Economist Intelligence Unit (a sister company of The Economist) shows how the two are filling a “vaccine vacuum” by helping poor countries secure doses. They have shipped millions of jabs to those stuck at the back of the global queue. Venezuela’s despot, however, has been touting a herbal quack cure for covid-19—while hospitals lack water and vaccines are scarce.In an invited article, Ashish Jha, dean of the Brown University School of Public Health, makes the case for vaccine passports to beat covid-19. People will only have confidence meeting together for work or leisure, he argues, if they have some certainty it is safe. We also published a counter-argument by Clare Wenham of the London School of Economics and a reflection on Israel’s experience by Rachel Azaria, a former member of the Knesset.On “The Jab”, our podcast reporting from the sharp end of the vaccination race, we consider what lessons the world should learn after more than a year living with covid-19. Also, what explains the vast discrepancies in the ways the pandemic seems to have affected different countries? Zanny Minton Beddoes Editor-In-Chief The Economist


Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di

Stai commentando usando il tuo account Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

%d blogger hanno fatto clic su Mi Piace per questo: